These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34983359)

  • 1. Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review.
    Potla N; Ganti L
    Int J Emerg Med; 2022 Jan; 15(1):1. PubMed ID: 34983359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Shen Z; Bao N; Tang M; Yang Y; Li J; Liu W; Jiang G
    Neurol Ther; 2023 Oct; 12(5):1553-1572. PubMed ID: 37552459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world comparative safety and efficacy of tenecteplase
    Psychogios K; Palaiodimou L; Katsanos AH; Magoufis G; Safouris A; Kargiotis O; Spiliopoulos S; Papageorgiou E; Theodorou A; Voumvourakis K; Broutzos E; Stamboulis E; Tsivgoulis G
    Ther Adv Neurol Disord; 2021; 14():1756286420986727. PubMed ID: 33488774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Huang J; Zheng H; Zhu X; Zhang K; Ping X
    Ann Med; 2024 Dec; 56(1):2320285. PubMed ID: 38442293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis.
    Katsanos AH; Psychogios K; Turc G; Sacco S; de Sousa DA; De Marchis GM; Palaiodimou L; Filippou DK; Ahmed N; Sarraj A; Menon BK; Tsivgoulis G
    JAMA Netw Open; 2022 Mar; 5(3):e224506. PubMed ID: 35357458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.
    Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G
    Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials.
    Kobeissi H; Ghozy S; Turfe B; Bilgin C; Kadirvel R; Kallmes DF; Brinjikji W; Rabinstein AA
    Front Neurol; 2023; 14():1102463. PubMed ID: 36756249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials.
    Liang H; Wang X; Quan X; Chen S; Qin B; Liang S; Huang Q; Zhang J; Liang Z
    Front Neurol; 2023; 14():1176540. PubMed ID: 37333014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S
    Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings.
    George M; Baby N; Paul R; Zabeer M; Thomas C
    J Clin Neurosci; 2021 Sep; 91():299-305. PubMed ID: 34373043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetic properties of alteplase and tenecteplase. The future of thrombolysis in acute ischemic stroke.
    Marè A; Lorenzut S; Janes F; Gentile C; Marinig R; Tereshko Y; Gigli GL; Valente M; Merlino G
    Expert Opin Drug Metab Toxicol; 2024; 20(1-2):25-36. PubMed ID: 38275111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dosing errors between tenecteplase and alteplase for management of acute ischemic stroke.
    Ray B; Janzen KM; Curran M; Adamson R; Allen L; Warach S; Daley M
    J Am Pharm Assoc (2003); 2023; 63(2):643-647. PubMed ID: 36623954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
    Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
    Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase in acute ischemic stroke: Review of the literature and expert consensus from the French Neurovascular Society.
    Olindo S; Albucher JF; Bejot Y; Berge J; Cordonnier C; Guillon B; Sablot D; Tardy J; Alamowitch S; Sibon I
    Rev Neurol (Paris); 2023 Mar; 179(3):150-160. PubMed ID: 36369068
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.